Skip to main content

BitFuFu Announces June 2026 Bitcoin Production and Operational Updates

SINGAPORE, July 10, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for June 2026. “During June, we continued executing our long-term strategy with a focus on enhancing operational quality and capital discipline,” said Leo Lu, Chairman and CEO of BitFuFu. “While optimizing our mining operations, we acquired and deployed 1,200 S21 XP units in June, increasing our self-owned hashrate to 3.5 EH/s. We have also signed agreements to acquire and deploy 2,000 additional S21 XP units in July, with full operational deployment expected to be completed during the month. In addition, during June, we secured 5.3 EH/s of hashrate from suppliers under a nine-month agreement, scheduled...

Continue reading

VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has declared a special cash dividend (the “Cash Dividend”) in connection with the previously announced merger (the “Merger”) with Yarrow Bioscience, Inc. (“Yarrow”) pursuant to the Agreement and Plan of Merger and Reorganization, dated December 17, 2025 (as amended, the “Merger Agreement”). The Cash Dividend, which VYNE estimates will be an aggregate of $16.5 million, or an estimated $0.38 per share, will be payable in cash to the stockholders and warrant holders of record as of July 22, 2026. The estimated cash dividend is based on VYNE’s good faith calculation of the amount by which VYNE’s net...

Continue reading

Cross Keys Capital Advises Solinsky EyeCare in Its Partnership with ReFocus Eye Health

Fort Lauderdale, FL, July 10, 2026 (GLOBE NEWSWIRE) — Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician practices and healthcare services companies, is pleased to announce it acted as the exclusive financial advisor to Solinsky EyeCare on its partnership with ReFocus Eye Health (“ReFocus”). Solinsky EyeCare is an 11-location comprehensive ophthalmology and optometry practice serving Greater Hartford, Connecticut. Founded by Dr. Alan Solinsky and now led by Managing Partner Dr. David Jeng, the practice’s team of six ophthalmologists and seven optometrists provides compassionate, personalized treatment across the full spectrum of eye care. Solinsky Eyecare’s services include cataract surgery, glaucoma, and retina treatment, LASIK, lid surgery, dry eye management,...

Continue reading

YXT.com Announces ADS Ratio Change to Be Effective on July 14, 2026

SUZHOU, China, July 10, 2026 (GLOBE NEWSWIRE) — YXT.com Group Holding Limited (the “Company” or “YXT.com”) (NASDAQ: YXT), a provider of AI-enabled enterprise productivity solutions, today announced that it will change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares from the current ratio of one (1) ADS representing three (3) ordinary shares to a new ratio of one (1) ADS representing thirty (30) ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change is expected to become effective on July 14, 2026, U.S. Eastern Time (the “Effective Date”). For YXT.com’s ADS holders, the ADS Ratio Change will have the same effect as a one-for-ten reverse ADS split. There will be no change to the Company’s ordinary shares, and no ordinary shares will be issued or cancelled in connection with the ADS Ratio Change. On...

Continue reading

NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression

Independent flow cytometry (FACS) study will quantify latent myostatin antigen expression on NorthStrive-manufactured Lactobacillus casei and establish comparability against EL-22 material previously manufactured by MOA Life Plus Co. Ltd. Work is intended to strengthen EL-22 product identity and manufacturing consistency as NorthStrive advances a differentiated engineered probiotic designed to help preserve muscle during weight loss, including with GLP-1 receptor agonists NEWPORT BEACH, Calif., July 10, 2026 (GLOBE NEWSWIRE) — NorthStrive Biosciences Inc. (“NorthStrive Biosciences”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”), today announced plans to initiate an independent flow cytometry, or FACS, analysis program to further characterize EL-22, the Company’s engineered Lactobacillus casei-based...

Continue reading

Almadex Announces Sale of Royalty Interests

VANCOUVER, British Columbia, July 10, 2026 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) announces that it has entered into a royalty purchase agreement with Empress Royalty Corp. (“Empress”) pursuant to which Almadex and certain of its subsidiaries have agreed to sell to Empress a portfolio of net smelter return royalty interests on mineral properties in Canada, the United States and Mexico for aggregate consideration of US$2,500,000. The consideration payable to Almadex consists of US$1,000,000 in cash and 2,562,802 common shares of Empress, having an agreed value of US$1,500,000. The royalty portfolio includes certain 1.5% and 2.0% net smelter return royalties on precious and base metal projects, including royalties located in Mexico, British Columbia, Yukon and Nevada. Closing of the transaction...

Continue reading

QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting

Ness Ziona, Israel, July 10, 2026 (GLOBE NEWSWIRE) — QTREX Quantum Ltd. (Nasdaq: QTEX) (“QTREX” or the “Company”) a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure today announced the formation of QTREX USA, its new U.S. subsidiary serving as the Company’s dedicated platform for U.S. federal contract execution. The move follows QTREX’s recently announced operational AME deployment at a U.S. government laboratory conducting quantum computing programs, and is intended to support the Company’s federal government contracting activities in the United States. By establishing QTREX USA, the Company is building a U.S.-based commercial and operational structure designed to convert federal and defense opportunities into government contracts. QTREX USA will...

Continue reading

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities

NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its wholly owned subsidiary Zorronet has completed the transition of its core operations to a new data center. The new data center is designed to improve response times and cost efficiency, and to increase capacity for handling complex security events in real time. The new data center forms a key part of Zorronet’s infrastructure modernization and supports its business expansion. “Completing the transition to a new advanced data center is an important milestone,” said Idan Wasserman, CEO of Zorronet. “It improves our platform’s performance, scalability, and cost efficiency, allowing us to provide stronger real-time AI...

Continue reading

Barrick to Report Second Quarter 2026 Results on August 10

TORONTO, July 10, 2026 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) will release its second quarter 2026 results before markets open on Monday, August 10, 2026 at 6:00 AM ET. The management team will host a live webcast and presentation at 11:00 AM ET the same day, followed by a question-and-answer session with analysts. Event Details – August 10, 2026Results release – 6:00 AM ET Live webcast and presentation – 11:00 AM ETTo join the webcast, please register here. Presentation materials will be available on Barrick’s website prior to the event with a replay available soon after. About Barrick Mining Corporation Barrick is a leading global mining, exploration, and development company. With one of the largest portfolios of world-class and long-life gold and copper assets in the industry, Barrick’s operations...

Continue reading

OTC Markets Group Welcomes Tectonic Metals Inc. to OTCQX

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Tectonic Metals Inc. (TSX-V: TECT; OTCQX: TETOF), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. Tectonic Metals Inc. upgraded to OTCQX from the OTCQB® Venture Market. Tectonic Metals Inc. begins trading today on OTCQX under the symbol “TETOF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.